Rare cannabinoids that cannot practically be extracted from hemp will instead be manufactured by specially-created micro-organisms.
A new partnership between Cronos Group, a Canadian vertically integrated cannabis company, and Ginkgo Bioworks, a Massachusetts-based bioengineering specialist, will see Ginkgo modify the DNA of yeast so that it can produce cannabinoids in a fermentation process.
They include cannabidiolic acid (CBDA), a substance naturally present in the hemp plant, which is then turned into cannabidiol (CBD) when its chemical composition is altered through heating.
Restricted content. Do you want to read more?
Sign up NOW for 7 days FREE TRIAL and access our briefings section
CBD-Intel provides impartial, independent and premium market and regulatory analysis, legal tracking, and quantitative data for the cannabidiol (CBD) sector worldwide. Most content is available to subscribers only.
Interested in obtaining data on consumer behaviour?
Check out our new consumer survey report: CBD use in the UK market
CBD products are popular in the UK for a variety of reasons across a wide-ranging consumer base. This report offers a detailed picture of the UK CBD market, covering a range of topics such as reasons for use, length of use, consumer spending, purchase channels and user experiences and attitudes.